
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
Exthymic Corp has raised $10.2M in total funding. The most recent round was Seed.
Exthymic Corp is headquartered in San Diego, CA.
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
Cell therapy can cure cancer, but the way it is manufactured today means most patients who need it can't access it.
Exthymic is building cell therapy manufacturing capabilities, drawing on the founders' careers building manufacturing platforms and scaling production in the industry, aimed at getting these treatments to more patients.
Exthymic's CEO, Rich Stoner, was previously Chief Scientific Officer at Resilience, the large biomanufacturing company; Exthymic's backers include KdT Ventures and Alix Ventures.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.